US Bancorp’s CASI Pharmaceuticals CASI Stock Holding History

US Bancorp’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-27	Closed	–	–	3396
2013 Q3	$0	Buy	+27	New	+$513	﹤0.01%	3274

Other funds holding CASI

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

US Bancorp's CASI Position: Q4 2013 in Review

US Bancorp sold out of CASI Pharmaceuticals (CASI) in Q4 2013, closing a stake of 27 shares.

US Bancorp first reported a position in CASI in Q3 2013 and held it in 1 quarter. The position peaked at $0 in Q3 2013. 30 funds tracked by Wall St. Rank hold CASI as of Q4 2013.

US Bancorp reported no remaining CASI Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
US Bancorp sold 27 CASI Pharmaceuticals shares in Q4 2013.
US Bancorp first reported a position in CASI Pharmaceuticals in Q3 2013 and held it in 1 quarter.
US Bancorp's CASI Pharmaceuticals position peaked at $0 in Q3 2013.
30 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2013.

Based on US Bancorp's 13F filing for Q4 2013, filed 13 Feb 2014.